Instrumento Inactivo

Acciones Salix Pharmaceuticals, Ltd.

Acciones

Duración

Período

Estilo

Valeant Pharmaceuticals Intl : Le laboratoire canadien Valeant conclut l'acquisition de Salix	01/04/15
Endo : Valeant trumps Endo with $10.96 billion bid for Salix Pharma	17/03/15
Le recul du dollar a favorisé le rebond de Wall Street	16/03/15
Bank of Montreal : TSX climbs on upbeat sentiment ahead of Fed meeting	16/03/15
Wall St. bounces as dollar drops, Fed worries ease	16/03/15

Directores	Puesto	Edad	Desde
Robert Spurr PSD	President	-	-
John Temperato SAM	Sales & Marketing	59	-

Sector

	Varia. 1 de ene.	Capi.
MERCK KGAA	+5,31 %	70,44 mil M
KYOWA KIRIN CO. LTD.	+10,97 %	8939,13 M
SK BIOPHARMACEUTICALS CO., LTD.	-16,83 %	4750,81 M
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.	+43,48 %	4497,76 M
YUHAN CORPORATION	+3,20 %	3845,87 M
INDIVIOR PLC	+18,82 %	2375,28 M
BETTA PHARMACEUTICALS CO., LTD.	-21,36 %	2341,22 M
CHANGCHUN BCHT BIOTECHNOLOGY CO.	-29,67 %	2196,26 M
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	+8,38 %	1963,71 M